Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

B-type suppression: A role played by "regulatory B cells" or "regulatory plasma cells"?
Diffusion-weighted imaging thermometry in multiple sclerosis.
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
Multiple sclerosis guideline production takes off.
Autophagy Is Required for Neutrophil-Mediated Inflammation.
Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Prevalence of multiple sclerosis in Brazil: A systematic review.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Clustering of autoimmune diseases in patients with rosacea.
Microglia in central nervous system repair after injury.
Acute transverse myelitis in childhood: A single centre experience from North India.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Agent Orange Exposure and Prevalence of Self-reported Diseases in Korean Vietnam Veterans.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Remote control-triggering of brain autoimmune disease in the gut.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Ongoing clinical trials of TYSABRI

Pages